Page last updated: 2024-11-03

probenecid and Enterovirus Infections

probenecid has been researched along with Enterovirus Infections in 1 studies

Probenecid: The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy.
probenecid : A sulfonamide in which the nitrogen of 4-sulfamoylbenzoic acid is substituted with two propyl groups.

Enterovirus Infections: Diseases caused by ENTEROVIRUS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sethy, B1
Hsieh, CF1
Yeh, C1
Horng, JT1
Hsieh, PW1

Other Studies

1 other study available for probenecid and Enterovirus Infections

ArticleYear
Design, synthesis & structure-activity relationships of a new class of antihuman enterovirus D68 & A71 agents.
    Future medicinal chemistry, 2018, 06-01, Volume: 10, Issue:11

    Topics: Animals; Antiviral Agents; Cell Line; Cell Survival; Drug Design; Drug Evaluation, Preclinical; Drug

2018